Characteristic | Transfused (n = 2,912) | Nontransfused (n = 1,432) | P value |
---|---|---|---|
Sex (% female) | 46.8 | 42.9 | 0.018 |
Age (years; mean ± SD) | 62.0 ± 16.5 | 60.4 ± 16.2 | 0.0014 |
Race (%) | |||
African American | 55.5 | 61.9 | <0.0001 |
Caucasian | 36.9 | 32.7 | |
Other | 8.6 | 5.4 | |
Chronic concomitant comorbidities, % | |||
Cardiac disease | 88.0 | 79.8 | <0.0001 |
Hypertension | 69.4 | 65.9 | 0.02 |
Anemia | 64.7 | 22.8 | <0.0001 |
Pulmonary disease | 64.6 | 65.9 | 0.43 |
Gastrointestinal disease | 57.6 | 31.1 | <0.0001 |
Central nervous system disease | 50.8 | 44.8 | 0.0002 |
Cancer | 39.1 | 26.1 | <0.0001 |
Immunologic disease | 38.9 | 22.8 | <0.0001 |
Thromboembolic disease | 38.5 | 30.0 | <0.0001 |
Renal disease | 35.3 | 15.8 | <0.0001 |
Diabetes | 31.6 | 26.1 | 0.0002 |
Musculoskeletal disease | 31.4 | 14.6 | <0.0001 |
Peripheral vascular disease | 29.2 | 26.9 | <0.0001 |
Cerebrovascular disease | 28.7 | 21.7 | 0.11 |
Primary hematologic disease | 15.2 | 7.5 | <0.0001 |